Dr. Hofit Cohen

Dr. Hofit Cohen

Sheba Medical Center

Israel Israel

Areas of Expertise Endocrinology, metabolism and lipid disorders. Education 1985-1992, Hebrew University, Hadassah Medical School, Jerusalem, Israel. Residencies and Further Training 2000, Israeli Board certified in Internal Medicine, 2004 Israeli Board certified in Endocrinology. Affiliations Tel Aviv University, Tel Aviv, Israel. Research Interests Lipid disorders in children and adolescents, cardiovascular preclinical risk assessment, metabolism of fatty acids, metabolism of omega-3 fatty acids, metabolic and lipid disorders in Cerebrotendinous xanthomatosis. Publications A list of publications for Dr. Hoffit Cohen is in PubMed. PubMed is a database that includes a listing of scientific articles in the fields of medicine and life sciences. Research Grants &Awards 2002-2007, 9-cis retinoic Acid-Lipid Metabolism & Atherogenesis, Nikken-Shohonsha-Japan (200,000$). 2013-2014, Tel Aviv University, Tel-Aviv, Israel, Cardiovascular risk assessment in survivors of Hodgkin's lymphoma (37,000 Shekel). Prizes ​​​​​November 1999, Prize for best abstract research day at the Chaim Sheba Medical Center, Tel Hashomer, Israel: PDX-1 is sufficient to induce insulin gene expression in mature liver, in –vivo and ameliorate STZ diabetes. Halkin, A, Cohen H, Ber I, Einav Y, Seijffers R, Cohen Y, Barshack I, Goldberg I, ,Kopolovic J, Karasik A, Ferber S. May 2001, Prize for best lecture in the 7th annual meeting of the society for research, prevention and treatment of atherosclerosis. Eilat, Israel. Cohen H, Sherer Y, Shaish A, Shoenfeld Y, Levkovitz, Bitzur R, Harats D. Magnesium chloride inhibits atherogenesis in LDL– receptor deficient mice. October 2004, Prize for best poster - annual meeting of the Israeli society for research, prevention and treatment of atherosclerosis, Israel. Shaish A, Harari A, Hananshvili L, Cohen H, Bitzur R, Luvish T, Ulman E ,Golan M, Ben-Amotz A, Gavish D, Rotstein Z, Harats D. 9-cis beta-carotene-rich powder of the alga Dunaliella bardawil improves fibrate action on plasma HDL-cholesterol. May 2010, best poster 2010 Sheba medical center – research day.

SPEAKER


CTX in Israel  15:50-16:05